Selected research
Market Structure
Global Medical Devices Genotoxicity Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Devices Genotoxicity Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Devices Genotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Devices Genotoxicity Testing Service include TÜV SÜD, NAMSA, Eurofins Scientific, SGS SA, Nelson Labs, CD Bioarticle, UL Solutions, Measurlabs and STC Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Medical Devices Genotoxicity Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Devices Genotoxicity Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Devices Genotoxicity Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Devices Genotoxicity Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Devices Genotoxicity Testing Service Segment by Company
TÜV SÜD
NAMSA
Eurofins Scientific
SGS SA
Nelson Labs
CD Bioarticle
UL Solutions
Measurlabs
STC Group
STEMart
Porsolt
TheraIndx
GBA Group
Adita Biosys
Adgyl Lifesciences
Medical Devices Genotoxicity Testing Service Segment by Type
In Vitro Testing
In Vivo Testing
Medical Devices Genotoxicity Testing Service Segment by Application
Implantable Devices
Polymer Devices
Drug Coating/Combination Devices
Others
Medical Devices Genotoxicity Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Devices Genotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Devices Genotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Devices Genotoxicity Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Devices Genotoxicity Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Devices Genotoxicity Testing Service industry.
Chapter 3: Detailed analysis of Medical Devices Genotoxicity Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Devices Genotoxicity Testing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In Vitro Testing
- In Vivo Testing
Applications
- Implantable Devices
- Polymer Devices
- Drug Coating/Combination Devices
- Others
Companies covered
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- SGS SA
- Nelson Labs
- CD Bioarticle
- UL Solutions
- Measurlabs
- STC Group
- STEMart
- Porsolt
- TheraIndx
- GBA Group
- Adita Biosys
- Adgyl Lifesciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 In Vitro Testing
- 1.2.3 In Vivo Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global Medical Devices Genotoxicity Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Implantable Devices
- 1.3.3 Polymer Devices
- 1.3.4 Drug Coating/Combination Devices
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Medical Devices Genotoxicity Testing Service Growth Trends by Region
- 1.5.1 Global Medical Devices Genotoxicity Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medical Devices Genotoxicity Testing Service Market Size by Region (2021-2026)
- 1.5.3 Medical Devices Genotoxicity Testing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medical Devices Genotoxicity Testing Service Market Dynamics
- 2.1 Medical Devices Genotoxicity Testing Service Industry Trends
- 2.2 Medical Devices Genotoxicity Testing Service Industry Drivers
- 2.3 Medical Devices Genotoxicity Testing Service Industry Opportunities and Challenges
- 2.4 Medical Devices Genotoxicity Testing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medical Devices Genotoxicity Testing Service Revenue by Company (2021-2026)
- 3.2 Global Medical Devices Genotoxicity Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medical Devices Genotoxicity Testing Service Key Company Head office and Area Served
- 3.4 Global Medical Devices Genotoxicity Testing Service Company, Product Type & Application
- 3.5 Global Medical Devices Genotoxicity Testing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medical Devices Genotoxicity Testing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medical Devices Genotoxicity Testing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Medical Devices Genotoxicity Testing Service Tier 1, Tier 2, and Tier 3
4 Medical Devices Genotoxicity Testing Service Market by Type
- 4.1 Global Medical Devices Genotoxicity Testing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2032)
- 4.3 Global Medical Devices Genotoxicity Testing Service Market Size Share by Type (2021-2032)
5 Medical Devices Genotoxicity Testing Service Market by Application
- 5.1 Global Medical Devices Genotoxicity Testing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2032)
- 5.3 Global Medical Devices Genotoxicity Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 TÜV SÜD
- 6.1.1 TÜV SÜD Company Information
- 6.1.2 TÜV SÜD Business Overview
- 6.1.3 TÜV SÜD Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 TÜV SÜD Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.1.5 TÜV SÜD Recent Developments
- 6.2 NAMSA
- 6.2.1 NAMSA Company Information
- 6.2.2 NAMSA Business Overview
- 6.2.3 NAMSA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 NAMSA Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.2.5 NAMSA Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Eurofins Scientific Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 SGS SA
- 6.4.1 SGS SA Company Information
- 6.4.2 SGS SA Business Overview
- 6.4.3 SGS SA Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 SGS SA Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.4.5 SGS SA Recent Developments
- 6.5 Nelson Labs
- 6.5.1 Nelson Labs Company Information
- 6.5.2 Nelson Labs Business Overview
- 6.5.3 Nelson Labs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Nelson Labs Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.5.5 Nelson Labs Recent Developments
- 6.6 CD Bioarticle
- 6.6.1 CD Bioarticle Company Information
- 6.6.2 CD Bioarticle Business Overview
- 6.6.3 CD Bioarticle Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 CD Bioarticle Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.6.5 CD Bioarticle Recent Developments
- 6.7 UL Solutions
- 6.7.1 UL Solutions Company Information
- 6.7.2 UL Solutions Business Overview
- 6.7.3 UL Solutions Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 UL Solutions Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.7.5 UL Solutions Recent Developments
- 6.8 Measurlabs
- 6.8.1 Measurlabs Company Information
- 6.8.2 Measurlabs Business Overview
- 6.8.3 Measurlabs Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Measurlabs Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.8.5 Measurlabs Recent Developments
- 6.9 STC Group
- 6.9.1 STC Group Company Information
- 6.9.2 STC Group Business Overview
- 6.9.3 STC Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 STC Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.9.5 STC Group Recent Developments
- 6.10 STEMart
- 6.10.1 STEMart Company Information
- 6.10.2 STEMart Business Overview
- 6.10.3 STEMart Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 STEMart Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.10.5 STEMart Recent Developments
- 6.11 Porsolt
- 6.11.1 Porsolt Company Information
- 6.11.2 Porsolt Business Overview
- 6.11.3 Porsolt Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Porsolt Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.11.5 Porsolt Recent Developments
- 6.12 TheraIndx
- 6.12.1 TheraIndx Company Information
- 6.12.2 TheraIndx Business Overview
- 6.12.3 TheraIndx Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 TheraIndx Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.12.5 TheraIndx Recent Developments
- 6.13 GBA Group
- 6.13.1 GBA Group Company Information
- 6.13.2 GBA Group Business Overview
- 6.13.3 GBA Group Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 GBA Group Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.13.5 GBA Group Recent Developments
- 6.14 Adita Biosys
- 6.14.1 Adita Biosys Company Information
- 6.14.2 Adita Biosys Business Overview
- 6.14.3 Adita Biosys Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Adita Biosys Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.14.5 Adita Biosys Recent Developments
- 6.15 Adgyl Lifesciences
- 6.15.1 Adgyl Lifesciences Company Information
- 6.15.2 Adgyl Lifesciences Business Overview
- 6.15.3 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Adgyl Lifesciences Medical Devices Genotoxicity Testing Service Product Portfolio
- 6.15.5 Adgyl Lifesciences Recent Developments
7 North America
- 7.1 North America Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 7.2 North America Medical Devices Genotoxicity Testing Service Market Size by Type
- 7.2.1 North America Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2026)
- 7.2.2 North America Medical Devices Genotoxicity Testing Service Market Size by Type (2027-2032)
- 7.2.3 North America Medical Devices Genotoxicity Testing Service Market Share by Type (2021-2032)
- 7.3 North America Medical Devices Genotoxicity Testing Service Market Size by Application
- 7.3.1 North America Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2026)
- 7.3.2 North America Medical Devices Genotoxicity Testing Service Market Size by Application (2027-2032)
- 7.3.3 North America Medical Devices Genotoxicity Testing Service Market Share by Application (2021-2032)
- 7.4 North America Medical Devices Genotoxicity Testing Service Market Size by Country
- 7.4.1 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 7.4.3 North America Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 7.4.4 North America Medical Devices Genotoxicity Testing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 8.2 Europe Medical Devices Genotoxicity Testing Service Market Size by Type
- 8.2.1 Europe Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Medical Devices Genotoxicity Testing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Medical Devices Genotoxicity Testing Service Market Share by Type (2021-2032)
- 8.3 Europe Medical Devices Genotoxicity Testing Service Market Size by Application
- 8.3.1 Europe Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Medical Devices Genotoxicity Testing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Medical Devices Genotoxicity Testing Service Market Share by Application (2021-2032)
- 8.4 Europe Medical Devices Genotoxicity Testing Service Market Size by Country
- 8.4.1 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Medical Devices Genotoxicity Testing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 9.2 China Medical Devices Genotoxicity Testing Service Market Size by Type
- 9.2.1 China Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2026)
- 9.2.2 China Medical Devices Genotoxicity Testing Service Market Size by Type (2027-2032)
- 9.2.3 China Medical Devices Genotoxicity Testing Service Market Share by Type (2021-2032)
- 9.3 China Medical Devices Genotoxicity Testing Service Market Size by Application
- 9.3.1 China Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2026)
- 9.3.2 China Medical Devices Genotoxicity Testing Service Market Size by Application (2027-2032)
- 9.3.3 China Medical Devices Genotoxicity Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 10.2 Asia Medical Devices Genotoxicity Testing Service Market Size by Type
- 10.2.1 Asia Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Medical Devices Genotoxicity Testing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Medical Devices Genotoxicity Testing Service Market Share by Type (2021-2032)
- 10.3 Asia Medical Devices Genotoxicity Testing Service Market Size by Application
- 10.3.1 Asia Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Medical Devices Genotoxicity Testing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Medical Devices Genotoxicity Testing Service Market Share by Application (2021-2032)
- 10.4 Asia Medical Devices Genotoxicity Testing Service Market Size by Country
- 10.4.1 Asia Medical Devices Genotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Medical Devices Genotoxicity Testing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medical Devices Genotoxicity Testing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst